Détail - canceropole-wordpress

AI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative Study.

Claessens A, Simon A, Manchart A, Desmonts L, Leguay C, Faivre JC, Cambier S, Salleron J, Lambert A

JMIR Cancer. 2026 02 23;12:e80268

Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical Trial.

Biau J, Sun X, Liem X, Faivre JC, Eker E, Blanchard P, Tao Y, Doré M, Maingon P, Vulquin N, Alfonsi M, Thureau S, Huguet F, Racadot S, Thivat E, Molnar I, Boisselier P, Guihard S, Gallocher O, Dupin C, Batard S, Bourhis J, Lapeyre M

JAMA Netw Open. 2025 12 1;8(12):e2549975

Radiotherapy of bone metastases: 2025 update.

Martz N, Faivre JC, Beldjoudi G, Arnaud A, Chamois J, Supiot S, Rogé M, Thureau S

Cancer Radiother. 2025 11 28;29(7-8):104769

Reirradiation of lung, breast and bone tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique.

Zhou Y, Escande A, Beddok A, Chargari C, Sunyach MP, Ayadi M, Khalifa J, Antoni D, Cao K, Pasquier D, Hannoun-Lévi JM, Langé M, Faivre JC, Thureau S, Supiot S

Cancer Radiother. 2025 11 28;29(7-8):104780

Management of radiation-induced gynecological toxicities: AFSOS-SFCE-GFRCP clinical practice guidelines.

Bruand M, Kanoun D, Le Tinier F, Rousset-Jablonski C, Nadjafizadeh S, Nimubona D, Demoor-Goldschmitt C, Martz N, Gehin W, Charra-Brunaud C, Monpetit E, Faivre JC

Int J Gynecol Cancer. 2025 11 24;36(2):102817

Quality and safety in radiation oncology: Innovation and beyond.

Pourel N, Parent L, Faivre JC, Pellen E, Lorchel F, Brusadin G

Cancer Radiother. 2025 11 20;29(7-8):104766

Combining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group.

Golfier C, Visy A, Gueiderikh A, Marcel J, Escande A, Scala-Bertola J, Metzger M, Lambert A, Faivre JC

Cancer Metastasis Rev. 2025 11 14;44(4):83

Guidelines about radiotherapy and oncologic systemic treatments: Stop or continue?

Buchalet C, Golfier C, Faivre JC, Azria D, Kirova Y, Lapierre A, Latorzeff I, Mirjolet C, Hennequin C, Leroy T, Marcel J

Cancer Radiother. 2025 10 16;29(7-8):104757

Novel use of stereotactic ablative radiotherapy for refractory ventricular tachycardia with cardiac metastasis of primary renal cell carcinoma: a case report.

Cravéreau O, Stefani A, Buchheit I, Loustaud T, Grimon A, Gehin W, Martz N, Bruand M, Simon C, Marchesi V, De Chillou C, Sellal JM, Faivre JC

Cardiooncology. 2025 10 15;11(1):91

Radiation therapist, a key player in radiotherapy research.

Boisbouvier S, Hulot-Geffroy C, Boucaud A, Tachin-Bourgeon C, Salesses F, Faivre JC

Cancer Radiother. 2025 08 6;29(5-6):104686

State of the art: How to avoid unnecessary radiotherapy?

Faivre JC, Jung P, Morel É, Haaser T, Ruffier-Loubière A

Cancer Radiother. 2025 08 6;29(5-6):104685

[Recommendations on the prevention and management of radiation-induced lung injury from the Association francophone pour les soins oncologiques de support and the Société française de radiothérapie oncologique].

Cravéreau O, Bourbonne V, Vaugier L, Lucia F, Le Tinier F, Cadranel J, Duchemann B, Habert P, Martz N, Gehin W, Bruand M, Stefani A, Marcel J, Trampetti I, Clément-Duchêne C, Lerouge D, Laville A, Cao K, Pourel N, Zaccariotto A, Bellière-Calendry A, Thillays F, Tanguy R, Antoni D, Girard N, Martin É, Godbert B, Nakad A, Treffel G, Massin M, Charzat V, Thureau S, Lapierre A, Faivre JC

Cancer Radiother. 2025 08 6;29(5-6):104687

AFSOS-SFRO Guidelines on Radiation-Induced Lung Injury.

Cravereau O, Bourbonne V, Vaugier L, Lucia F, Tinier FL, Cadranel J, Duchemann B, Habert P, Martz N, Gehin W, Bruand M, Stefani A, Marcel J, Trampetti I, Clement-Duchene C, Lerouge D, Laville A, Cao K, Pourel N, Zaccariotto A, Belliere-Calendry A, Thillays F, Tanguy R, Antoni D, Girard N, Martin E, Godbert B, Nakad A, Treffel G, Massin M, Charzat V, Thureau S, Lapierre A, Faivre JC

Clin Lung Cancer. 2025 07 17;:

Evolution of radiation oncology training in France: Over 20 years of the role of the Société Française des Jeunes Radiothérapeutes Oncologues (SFjRO, the French society of young radiation oncologists).

Larnaudie A, Ghannam Y, El Houat Y, Michalet M, Huguet F, Camps-Maléa A, Faivre JC, Pointreau Y, Leroy T, Escande A, Lesueur P, Thureau S, Raynaud C, Latorzeff I, Liem X, Blanchard P, Rivera S, Bibault JE, Tolédano A, Janoray G, Lafond C, Ollivier L

Cancer Radiother. 2025 04 30;29(2):104620

State-of-the-art of multidisciplinary approach of bone metastasis-directed therapy: review and challenging questions for preparation of a GEMO practice guidelines.

Mesny E, Martz N, Stacoffe N, Clarençon F, Louis M, Mansouri N, Sirveaux F, Thureau S, Faivre JC

Cancer Metastasis Rev. 2025 04 12;44(2):45

Clinical practice in stereotactic radiotherapy delivery at treatment unit: a practitioner survey and consensus-based recommendations for multidisciplinary professional development.

Martz N, Marchesi V, Rogé M, Verry C, Clavère P, Peignaux K, Belkacemi Y, Coutte A, Vendrely V, Antoni D, Champeau-Orange E, Thureau S, Aabibou K, Drouin C, Grimon A, Monod C, Farasse P, Supiot S, Faivre JC,

Radiat Oncol. 2025 03 13;20(1):36

Successful Radiotherapy in Management of Inoperable Trichoblastic Carcinoma: A Case Report.

Colin S, Faivre JC, Devoti JF, Granel-Brocard F, Renard S

Am J Case Rep. 2025 02 26;26:e945865

Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art.

Gueiderikh A, Faivre JC, Golfier C, Escande A, Thureau S

Cancer Metastasis Rev. 2025 01 29;44(1):28

Survival without Quality of Life Deterioration in the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial in Head and Neck Cancer Patients with Oligometastases using Stereotactic Ablative Radiotherapy (SABR)-alone or chemotherapy SABR.

Thariat J, Bosset M, Falcoz A, Vernerey D, Pointreau Y, Racadot S, Faivre JC, Castelli J, Guihard S, Huguet F, Chapet S, Tao Y, Borel C, Fayette J, Rambeau A, Ferrand FR, Pechery A, Bourhis J, Sun XS

Int J Radiat Oncol Biol Phys. 2024 11 27;:

Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas.

Meyer C, Huger S, Bruand M, Leroy T, Palisson J, Rétif P, Sarrade T, Barateau A, Renard S, Jolnerovski M, Demogeot N, Marcel J, Martz N, Stefani A, Sellami S, Jacques J, Agnoux E, Gehin W, Trampetti I, Margulies A, Golfier C, Khattabi Y, Olivier C, Alizée R, Py JF, Faivre JC

Radiat Oncol. 2024 11 21;19(1):168

Management of unilateral neck irradiation in elderly patients with head and neck cancer: Which place for hypofractionation? A single-centre experience of 43 patients.

Rakotosamimanana M, Renard-Oldrini S, Sahki N, Faivre JC

Cancer Radiother. 2024 11 21;:

Reirradiation of bone metastasis: A narrative review of the literature.

Agnoux E, Gehin W, Stefani A, Marchesi V, Martz N, Faivre JC

Cancer Radiother. 2024 10 9;:

[Update of guidelines of the AFSOS, SFRO, SFH, SFNCM, SFCE, GFRP for the management of radio-induced nausea and vomiting].

Faivre JC, Demoor-Goldschmitt C, Beddok A, Schmitt A, Malgras A, Quilliot D, Fabre J, Perrot A, Jovenin N, Dupin C, Pointreau Y, Scotté F, Bensadoun RJ, Charzat V, Thariat J

Bull Cancer. 2024 10 8;:

13-year survival oligometastatic Merkel cell carcinoma: a case report.

Trampetti I, Faivre JC, Geoffrois L, Gehin W, Renard S

J Med Case Rep. 2024 09 18;18(1):455

Recommendations for Post-Operative Radiotherapy after complete resection of Thymoma - a French DELPHI consensus initiative.

Basse C, Khalifa J, Thillays F, Le Pechoux C, Maury JM, Bonte PE, Coutte A, Pourel N, Bourbonne V, Pradier O, Belliere A, Le Tinier F, Deberne M, Tanguy R, Denis F, Padovani L, Zaccariotto A, Molina T, Chalabreysse L, Brioude G, Delatour B, Faivre JC, Cao K, Giraud P, Riet FG, Thureau S, Antoni D, Massabeau C, Keller A, Bonnet E, Lerouge D, Martin E, Girard N, Botticella A

J Thorac Oncol. 2024 04 10;:

Clinical trials that will change practices: News in palliative radiotherapy.

Agnoux E, Renan A, Faivre JC

Cancer Radiother. 2023 10 25;:

Stereotactic body radiation therapy for bone oligometastases.

Naessens C, Chamois J, Supiot S, Faivre JC, Arnaud A, Thureau S

Cancer Radiother. 2023 10 12;:

CyberKnife stereotactic radiation therapy for stage I lung cancer and pulmonary oligometastases: is fiducial implantation still relevant?-a cohort study.

Oudin V, Salleron J, Marchesi V, Peiffert D, Khadige M, Faivre JC

J Thorac Dis. 2023 09 28;15(9):4636-4647

[Real world data in radiotherapy: A data farming project by Unitrad].

Guihard S, Piot M, Issoufaly I, Giraud P, Bruand M, Faivre JC, Eugène R, Liem X, Pasquier D, Lamrani-Ghaouti A, Ghannam Y, Ruffier A, Guilbert P, Larnaudie A, Thariat J, Rivera S, Clavier JB

Cancer Radiother. 2023 07 28;:

Hypofractionated radiotherapy for invasive squamous cell carcinoma of the scalp in the elderly: Efficacy and tolerance, preliminary results.

Jacques J, Renard S, Demogeot N, Faivre JC, Peiffert D

Cancer Radiother. 2023 05 11;:

Comparison between the HyperArc™ technique and the CyberKnife® technique for stereotactic treatment of brain metastases.

Guinement L, Salleron J, Buchheit I, Gérard K, Faivre JC, Royer P, Marchesi V

Cancer Radiother. 2023 02 14;:

Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.

Faivre JC, Jung P, Salleron J, Baumard F, Courrech F, Marchal F, Peiffert D, Renard S, Charra-Brunaud C

J Contemp Brachytherapy. 2023 02;15(1):27-36

Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?

Py JF, Salleron J, Vogin G, Courrech F, Teixeira P, Colnat-Coulbois S, Baumard F, Thureau S, Supiot S, Peiffert D, Oldrini G, Faivre JC

Cancer Radiother. 2023 01 12;:

Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.

Bruand M, Salleron J, Guihard S, Crety CM, Liem X, Pasquier D, Lamrani-Ghaouti A, Charra-Brunaud C, Peiffert D, Clavier JB, Desandes E, Faivre JC

BMC Cancer. 2022 12 16;22(1):1318

Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey.

Vilotte F, Pasquier D, Blanchard P, Supiot S, Khalifa J, Schick U, Lacornerie T, Vieillevigne L, Marre D, Chapet O, Latorzeff I, Magne N, Meyer E, Cao K, Belkacemi Y, Bibault JE, Berge-Lefranc M, Faivre JC, Gnep K, Guimas V, Hasbini A, Langrand-Escure J, Hennequin C, Graff P

Clin Transl Radiat Oncol. 2022 11;37:33-40

AFSOS-SFRO-SFH-SFNEP-SFCE-GFRP guidelines on radio-induced nausea and vomiting.

Faivre JC, Tomaszewski F, Demoor-Goldschmitt C, Beddok A, Malgras A, Schmitt A, Fabre J, Perrot A, Jovenin N, Salleron J, Clavère P, Pointreau Y, Scotté F, Bensadoun RJ, Block V, Thariat J

Crit Rev Oncol Hematol. 2022 10 9;:103825

Impact of radiotherapy on survival in resected or unresectable anaplastic thyroid carcinomas, a Rare Cancer Network study.

Sun XS, Le Guevelou J, Jacquemin J, Drouet Y, Sio TS, Bar-Sela G, Carrie C, Faivre JC, Khalifa J, Demiroz C, Qiu H, Schick U, Atalar B, Fakhry N, Mengue L, Pan J, Servagi-Vernat S, Thariat J

Cancer Radiother. 2022 06 14;:

[Stereotactic body radiation therapy for non-spine bone oligometastatic disease].

Faivre JC, Marchesi V, Thureau S

Cancer Radiother. 2021 Dec;25(8):837-842

[Stereotactic body radiation therapy for spine bone oligometastatic disease].

Thureau S, Rogé M, Marchesi V, Hadj Henni A, Faivre JC

Cancer Radiother. 2021 Dec;25(8):830-836

Histosurgical mapping of endoscopic endonasal surgery of sinonasal tumours to improve radiotherapy guidance.

Leleu T, Bastit V, Doré M, Kammerer E, Florescu C, Alfonsi M, Troussier I, Bensadoun RJ, Biau J, Blais E, Coutte A, Deberne M, Wiazzane N, Dupin C, Faivre JC, Giraud P, Graff P, Guihard S, Huguet F, Janoray G, Liem X, Pointreau Y, Racadot S, Schick U, Servagi-Vernat S, Sun XS, Thureau S, Villa J, Vulquin N, Wong S, Patron V, Thariat J

Cancer Radiother. 2021 Jun 23;:

Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary.

Abu-Shama Y, Salleron J, Carsuzaa F, Sun XS, Pflumio C, Troussier I, Petit C, Caubet M, Beddok A, Calugaru V, Servagi-Vernat S, Castelli J, Miroir J, Krengli M, Giraud P, Romano E, Khalifa J, Doré M, Blanchard N, Coutte A, Dupin C, Sumodhee S, Tao Y, Roth V, Geoffrois L, Toussaint B, Nguyen DT, Faivre JC, Thariat J

Cancers (Basel). 2021 May 17;13(10):

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III tr

Thureau S, Marchesi V, Vieillard MH, Perrier L, Lisbona A, Leheurteur M, Tredaniel J, Culine S, Dubray B, Bonnet N, Asselain B, Salleron J, Faivre JC

BMC Cancer. 2021 Feb 4;21(1):117

Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.

Pflumio C, Thomas J, Salleron J, Faivre JC, Borel C, Dolivet G, Sastre-Garau X, Geoffrois L

Oncol Rep. 2021 Jan 7;:

Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper.

Thureau S, Faivre JC, Assaker R, Biver E, Confavreux CB, Debiais F, Duterque-Coquillaud M, Giammarile F, Heymann D, Lecouvet FE, Morardet L, Paycha F, Body JJ, Vieillard MH

J Bone Oncol. 2020 Jun;22:100291

Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer.

Kissel M, Martel-Lafay I, Lequesne J, Faivre JC, Le Péchoux C, Stefan D, Barraux V, Loiseau C, Grellard JM, Danhier S, Lerouge D, Chouaid C, Gervais R, Thariat J

BMC Cancer. 2019 Dec 19;19(1):1237

10-Year Locoregional Control with Postoperative External Beam Radiotherapy in Patients with Locally Advanced High-Risk Non-Anaplastic Thyroid Carcinoma De Novo or at Relapse, a Propensity Score Analysis.

Servagi Vernat S, Khalifa J, Sun XS, Kammerer E, Blais E, Faivre JC, Sio TT, Pan J, Qiu H, Bar-Sela G, Simon JM, Salleron J, Thariat J

Cancers (Basel). 2019 Jun 19;11(6):

Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study.

Pflumio C, Troussier I, Sun XS, Salleron J, Petit C, Caubet M, Beddok A, Calugaru V, Servagi-Vernat S, Castelli J, Miroir J, Krengli M, Giraud P, Romano E, Khalifa J, Doré M, Blanchard N, Coutte A, Dupin C, Sumodhee S, Pointreau Y, Patel S, Rehailia-Blanchard A, Catteau L, Bensadoun RJ, Tao Y, Roth V, Geoffrois L, Faivre JC, Thariat J

Eur. J. Cancer. 2019 Feb 28;111:69-81

[Anal canal cancer: In the era of intensity-modulated radiotherapy, outstanding issues].

Peiffert D, Baumann AS, Serre AA, Vendrely V, Rouard N, Faivre JC, Vogin G

Cancer Radiother. 2018 Sep 1;:

Practical contouring guidelines with an MR-based atlas of brainstem structures involved in radiation-induced nausea and vomiting.

Beddok A, Faivre JC, Coutte A, Guévelou JL, Welmant J, Clavier JB, Guihard S, Janoray G, Calugaru V, Pointreau Y, Lacout A, Salleron J, Lefranc M, Hasboun D, Duvernoy HM, Thariat J

Radiother Oncol. 2018 Aug 29;:

Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03).

Faivre JC, Peiffert D, Vendrely V, Lemanski C, Hannoun-Levi JM, Mirabel X, Stanbury T, Salleron J, Guillemin F

Radiother Oncol. 2018 Aug 29;:

[Advances in the management of cervical lymphadenopathies of unknown primary with intensity modulated radiotherapy: Doses and target volumes].

Troussier I, Klausner G, Blais E, Giraud P, Lahmi L, Pflumio C, Faivre JC, Geoffrois L, Babin E, Morinière S, Maingon P, Thariat J

Cancer Radiother. 2018 May 3;:

Evaluation of the Theoretical Teaching of Postgraduate Radiation Oncology Medical Residents in France: a Cross-Sectional Study.

Faivre JC, Bibault JE, Leroy T, Agopiantz M, Salleron J, Wack M, Janoray G, Roché H, Culine S, Rivera S

J Cancer Educ. 2018 04;33(2):383-390

[Refusal of treatments by an adult cancer patient].

Dauchy S, Faivre JC, Block V, Metzger M, Salleron J, Charles C, Adam V

Bull Cancer. 2018 Mar;105(3):234-244

Choosing a career in oncology: results of a nationwide cross-sectional study.

Faivre JC, Bibault JE, Bellesoeur A, Salleron J, Wack M, Biau J, Cervellera M, Janoray G, Leroy T, Lescut N, Martin V, Molina S, Pichon B, Teyssier C, Thureau S, Mazeron JJ, Roché H, Culine S

BMC Med Educ. 2018 Jan 15;18(1):15

[Prophylactic radiotherapy in a single fraction of 10Gy at intervention pleural site in patient with malignant pleural mesothelioma: A retrospective monocentric cohort study].

Carette H, Faivre JC, Salleron J, Baumann AS, Uwer L, Clément-Duchêne C, Vignaud JM, Petit I, Siat J, Tiotiu A, Beckendorf V

Cancer Radiother. 2017 Dec;21(8):774-783

[Teaching pediatrics to residents via conventional lectures in France: A national survey from students].

Girard B, Bendavid M, Faivre JC, Salleron J, Debillon T, Claris O, Chabrol B, Schweitzer C, Gajdos V

Arch Pediatr. 2017 Aug;24(8):728-736

[Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?]

Royer P, Salleron J, Vogin G, Taillandier L, Clément-Duchêne C, Klein O, Faivre JC, Peiffert D, Bernier V

Cancer Radiother. 2017 Jul;:

Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer.

Faivre JC, Adam V, Block V, Metzger M, Salleron J, Dauchy S

Support Care Cancer. 2017 Jun;:

[Spinal stereotactic body radiotherapy: French assessment in 2016].

Pougnet I, Jaegle E, Garcia R, Tessier F, Faivre JC, Louvel G, Gross E, Gonzague L, Benchalal M, Ducteil A, Supiot S, Autret D, Clavier JB, Mirabel X, Bellière A, Wdowczyk D, Heymann S, Barillot I, de La Lande B, Passerat V, Sunyach MP, Lipinski F, Thibouw D, Guichard F, Chauvet B, Thariat J, Arnaud A

Cancer Radiother. 2017 May;:

Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment.

Darmon I, Morisse MC, Coutte A, Blonski M, Rhun EL, Taillandier L, Roufai DB, Desenclos C, Trudel S, Faivre JC, Blanchard N, Chauffert B, Boone M

J Cancer. 2017 ;8(8):1417-1424

[Conformal radiotherapy for vertebral bone metastasis].

Faivre JC, Py JF, Vogin G, Martinage G, Salleron J, Royer P, Grandgirard N, Pasquier D, Thureau S

Cancer Radiother. 2016 Oct;20(6-7):493-9

[Stereotactic body radiation therapy for spinal metastases].

Pasquier D, Martinage G, Mirabel X, Lacornerie T, Makhloufi S, Faivre JC, Thureau S, Lartigau É

Cancer Radiother. 2016 Oct;20(6-7):500-7

[Radiotherapy for anal canal cancers].

Peiffert D, Créhange G, Vendrely V, Baumann AS, Faivre JC, Huger S

Cancer Radiother. 2016 Sep;20 Suppl:S183-8

[Radiotherapy of rectal carcinoma].

Peiffert D, Créhange G, Vendrely V, Baumann AS, Faivre JC, Huger S, Serre AA

Cancer Radiother. 2016 Sep;20 Suppl:S179-82

[Adaptive radiation therapy for non-small cell lung cancer].

Bibault JE, Arsène-Henry A, Durdux C, Mornex F, Hamza S, Trouette R, Thureau S, Faivre JC, Boisselier P, Lerouge D, Paragios N, Giraud P

Cancer Radiother. 2015 Oct;19(6-7):458-62

[Radiotherapy of bone metastases: Which fractionations?].

Thureau S, Leysalle A, Faivre JC, Lagrange JL

Cancer Radiother. 2015 Oct;19(6-7):437-41

[Evaluation of the theoretical teaching of postgraduate medical students in France].

Faivre JC, Agopiantz M, Loeb E, Cassinari K, Wack M, Catoire P, Braun M, Thilly N, Coudane H

Rev Med Interne. 2015 Sep;36(9):579-87

[Evaluation of theoretical teaching of the French diploma of medical gynecology].

Agopiantz M, Scheffler F, Faivre JC, Bonne S, Catoire P, Weryha G, Gompel A

Gynecol Obstet Fertil. 2015 Jan;43(1):25-32

Mobile technology and social media in the clinical practice of young radiation oncologists: results of a comprehensive nationwide cross-sectional study.

Bibault JE, Leroy T, Blanchard P, Biau J, Cervellera M, Diaz O, Faivre JC, Fumagalli I, Lescut N, Martin V, Pichon B, Riou O, Thureau S, Giraud P

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):231-7

[Brachytherapy training: a survey of French radiation oncology residents].

Fumagalli I, Faivre JC, Thureau S, Bibault JE, Diaz O, Leroy T, Pichon B, Riou O, Fournier C, Hannoun-Levi JM, Peiffert D

Cancer Radiother. 2014 Jan;18(1):28-34

Radiotherapy for pain: modality of action and indications.

Faivre JC, Janvier L, Berger A, Mathias E, Olivier P, Bensadoun RJ, Peiffert D

Douleur Analg. 2013 Sep;26(3):152-7.

[Evaluation and management of acute radiation dermatitis].

Modesto A, Faivre JC, Granel-Brocard F, Tao YG, Pointreau Y

Cancer Radiother. 2012 Sep;16(5-6):456-61

MeMoPratic' VDHA guide: optimizing medical management from affected upper gastrointestinal system.

Faivre JC, Mecellem H, Albertini L, Belle A, Henry A, Rousselot H, Cretineau N, Montaut T, Chone L, Cabessut S, Bevilacqua S, Henneton C, Scotte F, Launay-Vacher V, Chenot ED, Desandes E, Toussaint S, Peiffert D, Krakowski I

. 2011 Mar;13(2-3):116-21.

MeMoPratic' VDHA guide: pain and supportive care: optimizing medical management from affected upper gastrointestinal system.

Faivre JC, Mecellem H, Albertini L, Belle A, Henry A, Rousselot H, Cretineau N, Montaut T, Chone L, Cabessut S, Bevilacqua S, Henneton C, Scotte F, Launay-Vacher V, Chenot ED, Desandes E, Toussaint S, Peiffert D, Krakowski I

. 2011 Mar;24(1):56-60.

Dr FAIVRE Jean-Christophe

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Publications

Retrouvez aussi